We have determined the nucleotide sequences of the capsid, E3, E2 and 6K genes of the avirulent Semliki Forest virus variant A774 (SFV A7). The sequence analysis revealed a nucleotide identity of 98% for capsid, 98 % for E3, 97 % for E2 and 98 % for 6K genes, as compared with the prototype SFV strain L10. At the protein level, the capsid and E3 polypeptides of SFV A7 both exhibited two amino acid substitutions, whereas point mutations in the 6K gene did not alter the amino acid sequence. In the E2 gene of SFV A7, seven of the 34 point mutations led to an amino acid difference as compared with the L10 strain. Replacement of the E2 glycoprotein gene of the virulent SFV4 clone with the corresponding region of SFV A7 resulted in a new plasmid construct, pME2, that gave rise to infectious virus CME2. CME2 and SFV4 replicated similarly in an immortalized mouse brain cell line (MBA 13). Intraperitoneal injection of 106 p.f.u, of CME2 into 4-to 6-week-old BALB/c mice caused mild clinical signs in some mice, whereas the majority of the infected animals remained asymptomatic, similar to infection with the avirulent SFV A7. In contrast, infection with the parental SFV4, a derivative of the virulent L10 strain, was lethal in 80 % of mice. Virus titres in blood and brain tissue specimens of BALB/c mice were similar after infection with CME2 or A7 viruses. The results suggest that amino acid differences in the E2 glycoprotein individually or in concert cause the attenuation of CME2.
Introduction
Virulent strains of Semliki Forest virus (SFV) such as L10 and its derivative SFV4 are neuropathic and cause death of BALB/c mice in a few days post-infection whereas infection with the phenotypically avirulent strain SFV A774 (SFV A7) is asymptomatic (Bradish et al., 1971 ; Balluz et al., 1993 ; Gates et al., 1985) . On the other hand, SFV A7 infection causes demyelination of the central nervous system (CNS), and has hence been widely used in pathogenicity studies of virus-induced demyelinating encephalitis (Fazakerley & Webb, 1987; Fazakerley et al., 1993) . SFV A7 infection also potentiates induction of experimental allergic encephalomyelitis (EAE), which is characterized by primary demyelination and clinical symptoms similar to those seen in the CNS of multiple sclerosis (MS) patients (Wu et al., 1988) . Structures of SFV affecting pathogenicity have been associated with the E2 spike glycoprotein in studies with laboratory mutants (Glasgow et al., 1991) , * Author for correspondence. Fax +358 21 6337000. e-mail ahinkkanen@finabo.abo.fi
The sequence data are deposited at the EMBL database under the following accession numbers: capsid, X78109; E3, X78110; E2, X78111; 6K, X78112. and more recently, amino acid (aa) residues involved in determining the phenotype of SFV A7 variants in pregnant mice have been identified (Glasgow et al., 1994) .
Monoclonal antibodies against the E2 glycoprotein have been successfully used to neutralize otherwise lethal SFV infection in mice (Boere et al., 1983) . The structural features causing the fatal outcome of CNS infections with virulent SFV strains are difficult to study by using phenotypically distinct virus strains that have not been characterized at the genomic level. Recently, we observed a high level of nucleotide identity in the E1 gene (98 %) between the virulent SFV L10 and the SFV A7 strains, but the 3' nontranslated regions (3'-NTR) differed remarkably (Santagati et al., 1994) .
In this study the nucleotide sequences of the SFV A7 genes coding for the capsid, E3, E2 and 6K polypeptides were determined and the deduced amino acid sequences compared to published SFV sequences. We also replaced a domain of the E2 gene of the virulent SFV4 clone containing six of the total seven amino acid substitutions with the corresponding E2 gene region of the avirulent SFV A7 virus. The resulting recombinant virus exhibited a highly attenuated phenotype in adult BALB/c mice indicating that the E2 polypeptide contains structures responsible for the reduced pathogenesis of the avirulent SFV A7.
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Methods
Virus strains and DNA sequencing. The avirulent Semliki Forest virus strain A774 (SFV A7) used in the present study was obtained from Dr H. E. Webb (The Rayne Institute, St Thomas' Hospital, London, UK). The virus was passaged in our laboratory five times in MBA 13 cells, a transformed mouse brain cell line (A. Salmi, unpublished) before it was plaque purified three times in MBA 13 cells. Preparation of an SFV A7 cDNA library and subcloning of A7 inserts into plasmid vectors has been described previously (Sautagati et al., 1994) . The nucleotide sequence of the A7 inserts was determined by the chain termination method (Sanger et al., 1977) using the Sequenase 2.0 kit (USB), and universal, reversed and SFV-specific primers (synthesized at the Department of Medical Microbiology, University of Turku). In order to exclude cloning artefacts, two independent cDNA inserts were sequenced and the results compared to other alphaviruses. The nucleotide sequence of the virulent L10 strain of SFV (Garoff et al., 1980 a, b; Takkinen, 1986 ) was used as the reference SFV sequence. The UWGCG program package (version 7.2) was used to analyse the data. The SFV full-length clone pSP6-SFV4 was kindly provided by Dr P. Liljestr6m (Department of Molecular Biology, Karolinska Institute, Stockholm).
PCR amplification of the SFV A7 E2 gene. Purified SFV A7 RNA (1 gg) was reverse transcribed (Moloney murine leukaemia virus reverse transcriptase; Pharmacia) with SFV-specific primers (forward, 5" GGATCCTAGGATCCTTGCTGCTATGAAAAC 3'; reversed, 5' TAAAGCTTGGTTTTGGTCCCACAA 3'). The SFV A7 fragment was cloned in the PCR TM II vector (Invitrogen) and sequenced. Additionally, the E2 sequence of A7 was verified on an independent cDNA clone.
Construction of plasmid carrying the E2 gene of SFV A7.
A recombinant Semliki Forest virus was generated by replacing the entire E2 gene region of the full-length SFV cDNA clone pSP6-SFV4 (Liljestr6m et al., 1991) with the corresponding gene region of SFV A7, except for 130 nucleotides at the C terminus. SFV4 is a virulent derivative of the prototype SFV LI0 strain (Glasgow et al., 1991) , and was recently shown to differ from L10 by one amino acid in the E2 spike glycoprotein (Glasgow et al., 1994) . Due to the large size of the expression vector several transient plasmids had to be constructed. First, the pSP6-SFV4 plasmid was digested with NotI (nt 6135)-Sphi (5" of SP6 promoter) to obtain a fragment containing the entire SFV structural gene region, including the 3'-NTR, and part of the nsp4 gene (Takkinen, 1986) . This was inserted into similarly digested pGEM5 to obtain the transient plasmid pM1. Digestion with XhoI (nt 8335) EcoRV (nt 9554) of pM1 removed the E2 gene (except the 130 Cterminal nucleotides) and allowed its replacement by the corresponding E2 region of SFV A7 obtained by PCR as described above. This cloning created the plasmid pM2, which was digested with Notl [(nt 6135) SpeI (nt 9049 and 3' of poly(A)] to give two fragments of the structural gene region (because there is a SpeI site within the E2 gene of A7, absent in L10). These gene regions were inserted into the pSP6-SFV4 plasmid in two steps. First the NotI (nt 6135)-Spel (nt 9049) fragment carrying nsp4, capsid, E3 and part of E2, was inserted in similarly digested pSP6-SFV4. The resulting plasmid pM3 was then linearized with SpeI and then the SpeI (nt 9049)-SpeI [3' of poly(A)] fragment from pM2 was inserted to give the final RNA expression vector pME2.
In vitro transcription. Plasmid pME2 (1 gg) was used as a template to produce RNA transcripts with the SP6/T7 transcription kit (Boehringer Mannheim) employing the SP6 promoter. The RNA product was analysed on a 0.8 % agarose gel on which the full-length transcript migrated along with the 4.5 kb band of the 2/HindIII DNA size standard.
Transfection of RNA and propagation of the recomb&ant virus. The in vitro transcribed RNA (1 gg) was transfected into 5 x 106 BHK-21 cells by electroporation (Liljestr6m et al., 1991) using the Bio-Rad Gene Pulser and 0.2 cm cuvettes. The transfected cells were then diluted 1 : 10 in complete BHK cell medium and transferred into 260 ml Nunclon cell culture bottles. At about 90 % completion of the cytopathic effect the infected cells were centrifuged at 4 °C and the supernatant was used as virus stock. For preparation of a large amount of recombinant virus (CME2) monolayer cultures of MBA 13 cells in a roller bottle were infected with the supernatant derived from BHK-21 cells after transfection. After 24 h incubation at 35 °C the supernatant was removed and fresh medium was added; 8 h later the supernatant was collected, clarified by centrifugation, and the virus was purified using sucrose step gradient (10/20/25/50%, w/v) eentrifugation at 24000 r.p.m, for 2.5 h in an SW 28 rotor (Beckman) at 4 °C. The viruscontaining fraction was diluted in phosphate buffered saline (PBS) and pelleted by centrifugation at 26000 r.p.m, for 1.5 h in the SW 28 rotor at 4 °C. Genomic RNA was purified as described by Ou et al. (1981) . Viral RNA was precipitated with 2.5 vols ethanol in the presence of 0.3 M-sodium acetate at --68 °C. To ascertain that we had obtained the desired hybrid genome, PCR over an informative gene region of the isolated RNA containing the mutations in E3 (nt 903) and in E2 (nt 1017) was performed followed by DNA sequence analysis.
Growth of SFV strains in a mouse brain cell line. Replication of SFV A7, SFV4 and CME2 viruses was studied using MBA 13 cell monolayers in 260ml culture flasks. The virus (m.o.i. = 10) was allowed to adsorb for 1 h at 37 °C, the monolayers were washed once with Hank's solution, and fresh culture medium was added. The cells were incubated at 37 °C, aliquots were collected at different time points, and the cells were removed by centrifugation. The samples were stored frozen at -68 °C until plaque titrated in MBA 13 cells. The results are expressed as the mean of two independent determinations.
Pathogenesis in BALB/c mice. For pathogenesis analysis, 4-to 6-week-old BALB/c mice were infected intraperitoneaUy (i.p.) with 106 p.f.u, of SFV4, SFV A7 or CME2 in PBS. The mice were observed daily and their clinical status was recorded. For titre determination another group of mice was infected and brain tissue and blood samples were collected daily. Sera from the blood samples were diluted in PBS containing 0.75% bovine serum albumin while brain homogenates were prepared in PBS by using a Polytron homogenizer. Diluted blood and brain samples were stored at -68 °C until assayed.
Results
Nucleotide sequence of the genes encoding the SFV A7 structural proteins
The nucleotide sequences of the SFV A7 and L10 genes encoding the capsid and the E3, E2 and 6K glycoproteins were aligned using UWGCG gap program. Table 1 summarizes the identities at the nucleotide and amino acid levels and the deduced amino acid similarities. The amino acid differences are shown in Table 2 . In each of the genes except in 6K, point mutations were found that led to amino acid substitution. In the capsid gene, the number of nucleotide substitutions (2) changing the corresponding amino acid was notably fewer than in the genes coding for the spike glycoproteins (6 or 7). One of the two amino acid exchanges, Asn-85 ~ Lys, resulting in an additional basic residue at the highly basic N- (1988) . Amino acid similarities were deduced using the gap program of the UWGCG package.
NA, Not applicable (because the Ross River virus 6K sequence is incomplete). terminal domain of the capsid protein (Table 2 ). There were no amino acid substitutions C-terminal from Lys-85 indicating that mutations in the 3'-terminal half of the capsid gene may affect the viability of the virus. In the E3 gene, Ala-12 --> Thr and Val-24 -~ Ala substitutions were found ( Table 2 ). The E2 gene of A7 differed from the corresponding region of the L 10 strain by 34 nucleotides. Seven of these caused an amino acid change, three of which were located in the transmembrane region ( Table  2 ). The E1 gene of SFV A7 was sequenced previously Two independent titrations were performed at each time point. (Santagati et al., 1994) ; the deduced amino acid sequence of this gene showed 98'6 % identity to the corresponding sequence of L10 (Table 1) .
Replication of the recomb#1ant virus in vitro
The multi-step cloning process for replacement of the E2 gene of SFV4 (see Methods) was followed by transcription in vitro of the plasmid pME2, which resulted in infectious RNA producing a hybrid virus (CME2). The CME2 virus was propagated in MBA 13 cells (a transformed mouse brain cell line) and was shown by PCR and sequencing to contain the correct E2 region originating from A7 (data not shown).
We first analysed the replication characteristics of CME2 in vitro using MBA 13 cells. Fig. 1 shows the time course of replication of SFV A7, CME2 and L10. Replication of strain A7 resulted in higher titres as compared with strains CME2 and SFV4. Only after a prolonged infection period (24 h) did the titre of strain SFV4 reach the level obtained with strain A7, whereas the recombinant CME2 virus showed lower values.
Pathogenicity studies of the CME2 virus
In order to study the pathogenesis of infection with CME2, SFV A7 and SFV4 strains in vivo, 4-to 6-weekold BALB/c mice were infected i.p. with l0 s p.f.u, in 100 Itl PBS. The mice were observed daily for 10 days. Mice infected with parental A7 virus appeared normal at all times, except that 1/20 of the infected mice died 1 day post infection (p.i.) (Fig. 2a), whereas among To compare the lethality and replication of the SFV strains two groups each with twenty 4-to 6-week old mice were infected i.p. with 106 p.f.u, of SFV A7 (O), CME2 (X) or SFV4 (/k). The mice were followed daily for 10 days. Serum samples were diluted in PBS. Brain samples were in PBS containing 0.75 % bovine sermll albumin. The virus titres of two mice were determined at each time point and the mean values are given.
infected with SFV4, the mortality was 80 %, similar to results reported by Glasgow et al. (1994) . In contrast, the phenotype of the hybrid CME2 was remarkably attenuated causing death of 1/20 of infected mice 5 days p.i. when the virus titre in the brain was at its maximum ( Fig. 2a, c) . Two CME2-infected mice showed slight hind limb paralysis and some had fur ruffing during the follow-up period of 10 days. Five untreated mice included in the experiment appeared normal.
To determine virus replication in vivo, the virus titres were measured in another group of 4-to 6-week-old BALB/c mice infected with 106 p.f.u, of CME2, A7 and SFV4 strains. Blood and brain samples were collected daily during the follow-up period of 10 days. Virus titres were analysed until day 10 p.i. (Fig. 2b, 2c) . SFV4 virus was cleared from the blood rapidly and was undetectable by day 3, whereas CME2 and A7 were cleared by day 4 and 5, respectively. Simultaneously, the titres of SFV4 in the brain tissue were several orders of magnitude higher than those observed in mice infected with SFV A7 or CME2.
Discussion
We have sequenced the genes encoding the capsid, E3, E2 and 6K structural proteins of the avirulent SFV A7 strain and shown that only a few nucleotide and amino acid changes are found in this attenuated strain as compared to the standard pathogenic strain L10. Our sequence is mainly in accordance with the SFV A7 sequence published recently by Glasgow et al. (1994) , although some differences were found (Santagati et al., 1994) . We have also constructed a recombinant virus strain (SFV CME2) which contains almost the entire E2 region from the attenuated A7 strain, and shown that this recombinant virus exhibits an attenuated phenotype in adult mice.
The capsid protein plays a critical role in the assembly of the SFV particle. The gene region encoding the capsid proteins of SFV A7 showed a high degree of identity with the SFV L10 sequence published by Garoff et al. (1980a, b) . One of the two amino acid substitutions, both of which were located at the N terminus, added a basic amino acid residue to the N terminus of the A7 capsid protein. This increases the positive charge which may have significance in RNA binding and nucleocapsid formation (Garoff et al., 1980b) . The observed high degree of conservation in the C-terminal domain of the capsid protein may be important for retaining the serine protease activity located at the C terminus (Melancon & Garoff, 1987) . Ross River virus capsid protein (Faragher et al., 1988) exhibits also a high homology of SFV at the C-terminal domain, whereas the N terminus is different.
The E3 spike protein is excised from the p62 precursor polypeptide shortly after its synthesis and plays an important role in membrane fusion (Garoff et al., 1980 b; de Curtis & Simons, 1988) . Although the substitutions Ala-12---> Thr and Val-24 ~ Ala in the E3 gene of A7 (Table 2) may not dramatically change the nature of the E3 protein, they may have an effect on the phenotype of the virus. For SFV L10, a single amino acid change in the E3 polypeptide chain has been shown to render the virus temperature sensitive due to blockage of virus budding (Syvfioja et al., 1990) . The three point mutations found in the 6K gene did not alter the amino acid sequence.
Four of the total seven amino acids found to be substituted in the E2 spike protein of SFV A7 reside outside the transmembrane domain, being thus potentially involved in the molecular interactions with the E1 polypeptide and cellular membrane structures during the virus life cycle. Monoclonal antibodies recognizing the E2 glycoprotein of the virulent strain of SFV have been shown to neutralize the virus, and injection of these antibodies prevents lethal SFV infection in mice (Boere et al., 1983) , indicating that the E2 protein may at least partly determine the severity of the infection. Mutation in the SFV E2 gene preventing the processing of the p62 protein has been shown to cause attenuation of the virulent SFV4 virus in adult mice (Glasgow et al., 1991) .
The SFV4 virus, which is a derivative of the L10 strain with similar virulence characteristics in adult mice (Glasgow et al., 1991) , has a lysine residue in the E2 gene at position aa 162 while glutamate is found in L10 and A7. In a recent study, mutation of SFV4 Lys-162 ~ Glu was found to attenuate the virus in pregnant BALB/c mice but had no significant effect on the pathogenicity in adult mice (Glasgow et al., 1994) . Substitution of the SFV4 E2 Lys-104 residue with Thr, found in SFV A7, did not alter the pathogenicity. Also, in Sindbis virus, changes in the E2 glycoprotein affect virulence (Pence et al., 1990; Tucker & Griffin, 1991) .
Our results from the mouse pathogenesis study with the hybrid SFV strain CME2 demonstrate that determinants reside within the E2 gene of the avirulent SFV A7 which, when used to replace the corresponding regions of virulent SFV4, attenuate virus pathogenesis in adult BALB/c mice. We have not yet identified the amino acid residues responsible for the attenuation. For example, it has been shown for Venezuelan equine encephalitis virus that individual amino acid mutations in the E2 gene cause synergistic attenuation (Davis et al., 1991) .
Although the hybrid SFV CME2 virus showed in vivo replication characteristics similar to the parental strain A7, it caused slight hind limb paralysis in 2/20 mice and fur ruffing in 6/20 mice indicating that SFV CME2 is somewhat less attenuated than A7. One explanation would be that attenuation of A7 is caused synergistically by mutations in E2 and other genes or NTRs recently shown to differ significantly between SFV A7 and L10 (Santagati et al., 1994) . Such a synergistic effect has been described for Sindbis virus E2 and E1 mutations (Lustig et al., 1988; Polo & Johnston, 1990; Russel et al., 1989) , and for Venezuelan equine encephalitis virus mutations in E2 and the 5' NTR (Kinney et aL, 1993) .
Both SFV4 and SFV A7 have been shown to infect cells of the mouse CNS, but A7 replicates less efficiently in neurons and oligodendrocytes (Fazakerley & Webb, 1987; Smyth et al., 1990; Balluz et al., 1993) . We are currently characterizing the mechanisms underlying the reduced replication of CME2 in CNS cells by exchange of the single amino acid residues of the E2 spike protein found to be different in the virulent strains. Finally, whether the E2 gene of the virulent strain SFV4 carries determinants that are able to increase the pathogenicity of the avirulent SFV A7 remains to be studied using a full-length A7 plasmid.
